Vallerie Mclaughlin
Director/Board Member at CLENE INC.
Net worth: - $ as of 30/03/2024
Profile
Vallerie V.
Mclaughlin is currently serving as the Chairman at the American College of Cardiology Foundation.
She is also an Independent Director at Clene Nanomedicine, Inc., Clene, Inc., and the University of Michigan, where she holds the position of Associate Chief Clinical Officer & Professor.
Previously, she served as the Chairman-Trustees Board at the Pulmonary Hypertension Association, Inc. and as the President at Southern Virginia University.
Dr. Mclaughlin obtained her doctorate degree from the Feinberg School of Medicine.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
CLENE INC
-.--% | 31/03/2024 | 0 ( -.--% ) | - $ | 30/03/2024 |
Vallerie Mclaughlin active positions
| Companies | Position | Start |
|---|---|---|
| CLENE INC. | Director/Board Member | 04/08/2021 |
Clene Nanomedicine, Inc.
 Clene Nanomedicine, Inc. Pharmaceuticals: MajorHealth Technology Clene Nanomedicine, Inc. is a clinical-stage biopharmaceutical company, which develops therapeutic candidates for neurodegenerative diseases. It focuses on the development of therapeutic nanocatalyst, CNM-Au8, for treatment of neurodegenerative diseases with a Phase 3 study underway in amyotrophic lateral sclerosis (ALS), and concurrent Phase 2 clinical programs ongoing for the neuroreparative treatment of multiple sclerosis, Parkinson's disease, and ALS. The company was founded by Reed N. Wilcox and Mark G. Mortenson in 2013 and and is headquartered in Salt Lake City, UT. | Director/Board Member | 04/08/2021 |
| University of Michigan | Corporate Officer/Principal | 31/12/2002 |
American College of Cardiology Foundation
 American College of Cardiology Foundation Medical/Nursing ServicesHealth Services American College of Cardiology Foundation provides cardiovascular education services. Its services include cardiac surgery, chronic angine, diabetes, geriatric cardiology and heart failure and cardiomyopathies. The company was founded by Franz Groedel, Robert P. Glover and Bruno Kisc in 1949 and is headquartered in Washington, DC. | Chairman | - |
Former positions of Vallerie Mclaughlin
| Companies | Position | End |
|---|---|---|
| Southern Virginia University | President | - |
Pulmonary Hypertension Association, Inc.
 Pulmonary Hypertension Association, Inc. Medical/Nursing ServicesHealth Services The Pulmonary Hypertension Association, Inc. is an organization that focuses on raising awareness and providing support for individuals with pulmonary hypertension. The private company is based in Silver Spring, MD. The company recently announced new dates for their PHA 2024 International PH Conference and Scientific Sessions, which will take place from August 15-18, 2024 at the JW Marriott. | Chairman | - |
Training of Vallerie Mclaughlin
| Feinberg School of Medicine | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| CLENE INC. | Health Technology |
| Private companies | 3 |
|---|---|
American College of Cardiology Foundation
American College of Cardiology Foundation Medical/Nursing ServicesHealth Services American College of Cardiology Foundation provides cardiovascular education services. Its services include cardiac surgery, chronic angine, diabetes, geriatric cardiology and heart failure and cardiomyopathies. The company was founded by Franz Groedel, Robert P. Glover and Bruno Kisc in 1949 and is headquartered in Washington, DC. | Health Services |
Pulmonary Hypertension Association, Inc.
Pulmonary Hypertension Association, Inc. Medical/Nursing ServicesHealth Services The Pulmonary Hypertension Association, Inc. is an organization that focuses on raising awareness and providing support for individuals with pulmonary hypertension. The private company is based in Silver Spring, MD. The company recently announced new dates for their PHA 2024 International PH Conference and Scientific Sessions, which will take place from August 15-18, 2024 at the JW Marriott. | Health Services |
Clene Nanomedicine, Inc.
Clene Nanomedicine, Inc. Pharmaceuticals: MajorHealth Technology Clene Nanomedicine, Inc. is a clinical-stage biopharmaceutical company, which develops therapeutic candidates for neurodegenerative diseases. It focuses on the development of therapeutic nanocatalyst, CNM-Au8, for treatment of neurodegenerative diseases with a Phase 3 study underway in amyotrophic lateral sclerosis (ALS), and concurrent Phase 2 clinical programs ongoing for the neuroreparative treatment of multiple sclerosis, Parkinson's disease, and ALS. The company was founded by Reed N. Wilcox and Mark G. Mortenson in 2013 and and is headquartered in Salt Lake City, UT. | Health Technology |
- Stock Market
- Insiders
- Vallerie Mclaughlin
